The Role of Smoothened-Dependent and -Independent Hedgehog Signaling Pathway in Tumorigenesis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of Smoothened-Dependent and -Independent Hedgehog Signaling Pathway in Tumorigenesis
Authors
Keywords
-
Journal
Biomedicines
Volume 9, Issue 9, Pages 1188
Publisher
MDPI AG
Online
2021-09-10
DOI
10.3390/biomedicines9091188
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic significance of hedgehog signaling network‐related gene expression in breast cancer patients
- (2021) Julia Kuehn et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Hallmarks of cancer—the new testament
- (2021) Sasi S. Senga et al. Open Biology
- GLI3 Promotes Invasion and Predicts Poor Prognosis in Colorectal Cancer
- (2021) Mingyang Shen et al. Biomed Research International
- Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial
- (2021) Michael Heuser et al. ANNALS OF HEMATOLOGY
- Hedgehog transcriptional effector GLI mediates mTOR-Induced PD-L1 expression in gastric cancer organoids
- (2021) Vivien Koh et al. CANCER LETTERS
- Smoothened Promotes Glioblastoma Radiation Resistance Via Activating USP3-Mediated Claspin Deubiquitination
- (2020) Yiming Tu et al. CLINICAL CANCER RESEARCH
- GANT61 and Valproic Acid Synergistically Inhibited Multiple Myeloma Cell Proliferation via Hedgehog Signaling Pathway
- (2020) Zhihua Zhang et al. MEDICAL SCIENCE MONITOR
- Hedgehog and Gpr161: Regulating cAMP Signaling in the Primary Cilium
- (2020) Philipp Tschaikner et al. Cells
- GLI1 Inhibitor SRI-38832 Attenuates Chemotherapeutic Resistance by Downregulating NBS1 Transcription in BRAFV600E Colorectal Cancer
- (2020) Ruowen Zhang et al. Frontiers in Oncology
- Gli1 regulates stemness characteristics in gastric adenocarcinoma
- (2020) Wenbo Qi et al. Diagnostic Pathology
- Phase I/II trial assessing hydroxychloroquine and itraconazole in women with advanced platinum-resistant epithelial ovarian cancer (EOC) (HYDRA-01).
- (2020) Ainhoa Madariaga et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcomes of Vismodegib for Periocular Locally Advanced Basal Cell Carcinoma From an Open-label Trial
- (2020) Meydan Ben Ishai et al. JAMA Ophthalmology
- Cohort analysis of safety and efficacy of vismodegib in Italian patients from the Phase II, multicenter STEVIE study
- (2020) Paolo Bossi et al. Future Oncology
- GLI1 expression in pancreatic ductal adenocarcinoma correlates the clinical significance and prognosis
- (2020) Ruidan Li et al. MEDICINE
- Targeting of the Hedgehog/GLI and mTOR pathways in advanced pancreatic cancer, a phase 1 trial of Vismodegib and Sirolimus combination
- (2020) Ryan M. Carr et al. PANCREATOLOGY
- Genetic and Epigenetic Regulation of the Smoothened Gene (SMO) in Cancer Cells
- (2020) Hong Lou et al. Cancers
- Safety and efficacy of the combination of sonidegib and ruxolitinib in myelofibrosis: a phase 1b/2 dose-finding study
- (2020) Vikas Gupta et al. Blood Advances
- The SHH/GLI signaling pathway: a therapeutic target for medulloblastoma
- (2020) Ludovica Lospinoso Severini et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- GANT61 and Lithium Chloride Inhibit the Growth of Head and Neck Cancer Cell Lines Through the Regulation of GLI3 Processing by GSK3β
- (2020) Vedran Zubčić et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Large-scale pan-cancer analysis reveals broad prognostic association between TGF-β ligands, not Hedgehog, and GLI1/2 expression in tumors
- (2020) Aurélien de Reyniès et al. Scientific Reports
- Efficacy of sonidegib in histologic subtypes of advanced basal cell carcinoma: Results from the final analysis of the randomized phase 2 Basal Cell Carcinoma Outcomes With LDE225 Treatment (BOLT) trial at 42 months
- (2020) Reinhard Dummer et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Gli affects the stemness and prognosis of epithelial ovarian cancer via homeobox protein NANOG
- (2020) Huan Zhao et al. Molecular Medicine Reports
- Targeting Hedgehog Pathway and DNA Methyltransferases in Uterine Leiomyosarcoma Cells
- (2020) Natalia Garcia et al. Cells
- HHIP Overexpression Suppresses Human Gastric Cancer Progression and Metastasis by Reducing Its CpG Island Methylation
- (2020) Yu Song et al. Frontiers in Oncology
- Gli Proteins: Regulation in Development and Cancer
- (2019) Paweł Niewiadomski et al. Cells
- Principles of tumorigenesis and emerging molecular drivers of SHH ‐activated medulloblastomas
- (2019) Otília Menyhárt et al. Annals of Clinical and Translational Neurology
- Hedgehog pathway proteins SMO and GLI expression as prognostic marker in head and neck squamous cell carcinoma - a retrospective immunohistochemical study
- (2019) Georg Richtig et al. HISTOPATHOLOGY
- GLI1 overexpression promotes gastric cancer cell proliferation and migration and induces drug resistance by combining with the AKT-mTOR pathway
- (2019) Yizhou Yao et al. BIOMEDICINE & PHARMACOTHERAPY
- A phase II study of S-1, oxaliplatin, and nab-paclitaxel, and itraconazole aimed at conversion surgery for advanced and recurrent gastric cancer.
- (2019) Yoshihiko Nakamoto et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib
- (2019) Aaron T. Gerds et al. LEUKEMIA RESEARCH
- Synergistic effect of arsenic trioxide, vismodegib and temozolomide on glioblastoma
- (2019) Costansia Bureta et al. ONCOLOGY REPORTS
- Recent Advances in the Clinical Targeting of Hedgehog/GLI Signaling in Cancer
- (2019) Hao Xie et al. Cells
- A phase 2 trial of the oral smoothened inhibitor glasdegib in refractory myelodysplastic syndromes (MDS)
- (2019) David A. Sallman et al. LEUKEMIA RESEARCH
- Structural basis of βTrCP1-associated GLI3 processing
- (2019) Shagufta Shafique et al. Scientific Reports
- Non-canonical Hedgehog Signaling Pathway in Cancer: Activation of GLI Transcription Factors Beyond Smoothened
- (2019) Silvia Pietrobono et al. Frontiers in Genetics
- Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis
- (2019) Yuchen Li et al. Acta Neuropathologica Communications
- Glasdegib plus intensive/nonintensive chemotherapy in untreated acute myeloid leukemia: BRIGHT AML 1019 Phase III trials
- (2019) Jorge E Cortes et al. Future Oncology
- 695PPhase I/II study of LDE225 in combination with gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer
- (2019) E N Pijnappel et al. ANNALS OF ONCOLOGY
- Phase 2 Trial of LDE225 and Lenalidomide Maintenance Post Autologous Stem Cell Transplant for Multiple Myeloma
- (2019) Francis K. Buadi et al. BLOOD
- Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer
- (2019) Angela L. McCleary-Wheeler et al. PANCREATOLOGY
- Hedgehog Signaling: An Achilles’ Heel in Cancer
- (2019) Madiha Niyaz et al. Translational Oncology
- SPOP Regulates The Biological Mechanism Of Ovarian Cancer Cells Through The Hh Signaling Pathway
- (2019) Yanxi Li et al. OncoTargets and Therapy
- Pharmacological mTOR targeting enhances the antineoplastic effects of selective PI3Kα inhibition in medulloblastoma
- (2019) Frank Eckerdt et al. Scientific Reports
- Mutation of the PTCH1 gene predicts recurrence of breast cancer
- (2019) Chih-Yang Wang et al. Scientific Reports
- Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma
- (2019) Ana De Jesus-Acosta et al. BRITISH JOURNAL OF CANCER
- Efficacy, rate of tumor response, and safety of a short course (12-24 weeks) of oral vismodegib in various histologic subtypes (infiltrative, nodular, and superficial) of high-risk or locally advanced basal cell carcinoma, in an open-label, prospective case series clinical trial
- (2019) Scott W. Fosko et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Novel-smoothened inhibitors for therapeutic targeting of naïve and drug-resistant hedgehog pathway-driven cancers
- (2018) Qing-rou Li et al. ACTA PHARMACOLOGICA SINICA
- A highlight on Sonic hedgehog pathway
- (2018) Gabriela Basile Carballo et al. Cell Communication and Signaling
- Phase I Study of LY2940680, a Smo Antagonist, in Patients with Advanced Cancer Including Treatment-Naïve and Previously Treated Basal Cell Carcinoma
- (2018) Johanna Bendell et al. CLINICAL CANCER RESEARCH
- Phase Ib Study of Glasdegib, a Hedgehog Pathway Inhibitor, in Combination with Standard Chemotherapy in Patients with AML or High-Risk MDS
- (2018) Michael R. Savona et al. CLINICAL CANCER RESEARCH
- Synergistic inhibition of the Hedgehog pathway by newly designed Smo and Gli antagonists bearing the isoflavone scaffold
- (2018) Simone Berardozzi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synergistic Cross-Talk of Hedgehog and Interleukin-6 Signaling Drives Growth of Basal Cell Carcinoma
- (2018) Christina Sternberg et al. INTERNATIONAL JOURNAL OF CANCER
- A phase I and pharmacokinetic study of taladegib, a Smoothened inhibitor, in Japanese patients with advanced solid tumors
- (2018) Hideki Ueno et al. INVESTIGATIONAL NEW DRUGS
- A phase Ib study of sonidegib (LDE225), an oral small molecule inhibitor of smoothened or Hedgehog pathway, in combination with docetaxel in triple negative advanced breast cancer patients: GEICAM/2012–12 (EDALINE) study
- (2018) Manuel Ruiz-Borrego et al. INVESTIGATIONAL NEW DRUGS
- Chemical, computational and functional insights into the chemical stability of the Hedgehog pathway inhibitor GANT61
- (2018) Andrea Calcaterra et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemia
- (2018) Melissa A. Burns et al. LEUKEMIA
- Molecular modeling study on resistance of WT/D473H SMO to antagonists LDE-225 and LEQ-506
- (2018) Jing Tu et al. PHARMACOLOGICAL RESEARCH
- Glaucocalyxin A exerts anticancer effect on osteosarcoma by inhibiting GLI1 nuclear translocation via regulating PI3K/Akt pathway
- (2018) Jianwei Zhu et al. Cell Death & Disease
- Wnt3a‑regulated TCF4/β‑catenin complex directly activates the key Hedgehog signalling genes Smo and Gli1
- (2018) Youpei Wang et al. Experimental and Therapeutic Medicine
- Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer
- (2018) Aurélie S. Cazet et al. Nature Communications
- Correlation of Gli1 and HER2 expression in gastric cancer: Identification of novel target
- (2018) Xinyu Shao et al. Scientific Reports
- SMO Inhibition Modulates Cellular Plasticity and Invasiveness in Colorectal Cancer
- (2018) Paolo Magistri et al. Frontiers in Pharmacology
- Glasdegib in combination with cytarabine and daunorubicin in patients with AML or high-risk MDS: Phase 2 study results
- (2018) Jorge E. Cortes et al. AMERICAN JOURNAL OF HEMATOLOGY
- Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia: results of a phase Ib trial
- (2018) Dale Bixby et al. BRITISH JOURNAL OF HAEMATOLOGY
- Itraconazole as a Non-Castrating Treatment for Biochemically Recurrent Prostate Cancer: a Phase 2 Study
- (2018) Mina Lee et al. Clinical Genitourinary Cancer
- Role of GLI Transcription Factors in Pathogenesis and Their Potential as New Therapeutic Targets
- (2018) Maja Sabol et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hedgehog pathway inhibition by topical patidegib to reduce BCC burden in patients with basal cell nevus (Gorlin) syndrome.
- (2018) Ervin H Epstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study).
- (2018) Laurent Mortier et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase Ib study to assess the efficacy and safety of vismodegib in combination with ruxolitinib in patients with intermediate- or high-risk myelofibrosis
- (2018) Stephen Couban et al. Journal of Hematology & Oncology
- Design of Hedgehog pathway inhibitors for cancer treatment
- (2018) Jitender Bariwal et al. MEDICINAL RESEARCH REVIEWS
- Downregulation of ASPP2 promotes gallbladder cancer metastasis and macrophage recruitment via aPKC-ι/GLI1 pathway
- (2018) Li Tian et al. Cell Death & Disease
- Hedgehog signaling induces PD-L1 expression and tumor cell proliferation in gastric cancer
- (2018) Jayati Chakrabarti et al. Oncotarget
- Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial
- (2017) N. Basset-Séguin et al. EUROPEAN JOURNAL OF CANCER
- Understanding the Molecular Genetics of Basal Cell Carcinoma
- (2017) Cristina Pellegrini et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial
- (2017) Brigitte Dréno et al. LANCET ONCOLOGY
- Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma
- (2017) Mark W Kieran et al. NEURO-ONCOLOGY
- Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma
- (2017) A Po et al. ONCOGENE
- Inhibition of hedgehog pathway reveals the regulatory role of SMO in gastric cancer cells
- (2017) Zixin Yang et al. TUMOR BIOLOGY
- Inhibition of Gli1‑mediated prostate cancer cell proliferation by inhibiting the mTOR/S6K1 signaling pathway
- (2017) Hong Yang et al. Oncology Letters
- Pharmacodynamic and pharmacokinetic neoadjuvant study of hedgehog pathway inhibitor Sonidegib (LDE-225) in men with high-risk localized prostate cancer undergoing prostatectomy
- (2017) Ashley E. Ross et al. Oncotarget
- Prognostic role of Gli1 expression in breast cancer: a meta-analysis
- (2017) Bilan Wang et al. Oncotarget
- KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer
- (2017) Andrew M. Waters et al. Cold Spring Harbor Perspectives in Medicine
- Regulation of Gli ciliary localization and Hedgehog signaling by the PY-NLS/karyopherin-β2 nuclear import system
- (2017) Yuhong Han et al. PLOS BIOLOGY
- A phase Ib trial of IPI-926, a hedgehog pathway inhibitor, plus gemcitabine in patients with metastatic pancreatic cancer.
- (2017) Donald Anthony Richards et al. JOURNAL OF CLINICAL ONCOLOGY
- Smoothened is a poor prognosis factor and a potential therapeutic target in glioma
- (2017) Yiming Tu et al. Scientific Reports
- Non-canonical GLI1/2 activation by PI3K/AKT signaling in renal cell carcinoma: A novel potential therapeutic target
- (2016) Jiancheng Zhou et al. CANCER LETTERS
- Nestin Mediates Hedgehog Pathway Tumorigenesis
- (2016) Peng Li et al. CANCER RESEARCH
- Thoughts on investigational hedgehog pathway inhibitors for the treatment of cancer
- (2016) Tarkan Jäger et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Galectin-1 from cancer-associated fibroblasts induces epithelial–mesenchymal transition through β1 integrin-mediated upregulation of Gli1 in gastric cancer
- (2016) Yang Chong et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2016) Jean Y Tang et al. LANCET ONCOLOGY
- A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer
- (2016) M. Catherine Pietanza et al. LUNG CANCER
- Suppressor of Fused Chaperones Gli Proteins To Generate Transcriptional Responses to Sonic Hedgehog Signaling
- (2016) Ziyu Zhang et al. MOLECULAR AND CELLULAR BIOLOGY
- Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition
- (2016) Yumi Miyazaki et al. Molecular Cancer
- Targeting the hedgehog transcription factors GLI1 and GLI2 restores sensitivity to vemurafenib-resistant human melanoma cells
- (2016) F Faião-Flores et al. ONCOGENE
- A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma
- (2016) Andrew H. Ko et al. PANCREAS
- Ciliary Entry of the Hedgehog Transcriptional Activator Gli2 Is Mediated by the Nuclear Import Machinery but Differs from Nuclear Transport in Being Imp-α/β1-Independent
- (2016) Belén Torrado et al. PLoS One
- Association between FOXM1 and hedgehog signaling pathway in human cervical carcinoma by tissue microarray analysis
- (2016) Hong Chen et al. Oncology Letters
- Hedgehog and TGFβ signaling converge on Gli2 to control bony invasion and bone destruction in oral squamous cell carcinoma
- (2016) Shellese A. Cannonier et al. Oncotarget
- In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors
- (2016) Monica Benvenuto et al. Oncotarget
- Prognostic and clinicopathological value of Gli-1 expression in gastric cancer: A meta-analysis
- (2016) Li Lu et al. Oncotarget
- DYRK1B blocks canonical and promotes non-canonical Hedgehog signaling through activation of the mTOR/AKT pathway
- (2016) Rajeev Singh et al. Oncotarget
- Galectin-1 induces invasion and the epithelial-mesenchymal transition in human gastric cancer cells via non-canonical activation of the hedgehog signaling pathway
- (2016) Yang Chong et al. Oncotarget
- Prognostic role of Gli1 expression in solid malignancies: a meta-analysis
- (2016) Ji Cheng et al. Scientific Reports
- The Hedgehog Signaling Networks in Lung Cancer: The Mechanisms and Roles in Tumor Progression and Implications for Cancer Therapy
- (2016) Yoshinori Abe et al. Biomed Research International
- Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma
- (2016) Mina S. Ally et al. JAMA Dermatology
- GSK3β and Gli3 play a role in activation of Hedgehog-Gli pathway in human colon cancer — Targeting GSK3β downregulates the signaling pathway and reduces cell proliferation
- (2015) Diana Trnski et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma
- (2015) Scott X. Atwood et al. CANCER CELL
- Cooperatively transcriptional and epigenetic regulation of sonic hedgehog overexpression drives malignant potential of breast cancer
- (2015) Zhao-Heng Duan et al. CANCER SCIENCE
- ErbB2 signaling activates the Hedgehog pathway via PI3K–Akt in human esophageal adenocarcinoma: Identification of novel targets for concerted therapy concepts
- (2015) Maxim Kebenko et al. CELLULAR SIGNALLING
- p53 modulates the activity of the GLI1 oncogene through interactions with the shared coactivator TAF9
- (2015) Joon Won Yoon et al. DNA REPAIR
- MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor
- (2015) Lucile Hoch et al. FASEB JOURNAL
- SOX9 inhibits -TrCP-mediated protein degradation to promote nuclear GLI1 expression and cancer stem cell properties
- (2015) W. Deng et al. JOURNAL OF CELL SCIENCE
- Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial
- (2015) Michael R Migden et al. LANCET ONCOLOGY
- Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial
- (2015) Nicole Basset-Seguin et al. LANCET ONCOLOGY
- Multisite interaction with Sufu regulates Ci/Gli activity through distinct mechanisms in Hh signal transduction
- (2015) Yuhong Han et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting GLI factors to inhibit the Hedgehog pathway
- (2015) Paola Infante et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Targeting the Hedgehog signaling pathway in cancer: beyond Smoothened
- (2015) Annelies Gonnissen et al. Oncotarget
- FOXC1 Activates Smoothened-Independent Hedgehog Signaling in Basal-like Breast Cancer
- (2015) Bingchen Han et al. Cell Reports
- Hedgehog Signaling in the Maintenance of Cancer Stem Cells
- (2015) Catherine Cochrane et al. Cancers
- Overlapping binding sites for importin β1 and suppressor of fused (SuFu) on glioma-associated oncogene homologue 1 (Gli1) regulate its nuclear localization
- (2014) Anette Szczepny et al. BIOCHEMICAL JOURNAL
- Inhibition of hedgehog signaling by GANT58 induces apoptosis and shows synergistic antitumor activity with AKT inhibitor in acute T cell leukemia cells
- (2014) Xiaoming Hou et al. BIOCHIMIE
- The PRKCI and SOX2 Oncogenes Are Coamplified and Cooperate to Activate Hedgehog Signaling in Lung Squamous Cell Carcinoma
- (2014) Verline Justilien et al. CANCER CELL
- Galectin-1 Drives Pancreatic Carcinogenesis through Stroma Remodeling and Hedgehog Signaling Activation
- (2014) N. Martinez-Bosch et al. CANCER RESEARCH
- Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer
- (2014) Rachelle W. Johnson et al. CLINICAL & EXPERIMENTAL METASTASIS
- A Phase I, Multicenter, Open-Label, First-in-Human, Dose-Escalation Study of the Oral Smoothened Inhibitor Sonidegib (LDE225) in Patients with Advanced Solid Tumors
- (2014) J. Rodon et al. CLINICAL CANCER RESEARCH
- CD44 Expression Denotes a Subpopulation of Gastric Cancer Cells in Which Hedgehog Signaling Promotes Chemotherapy Resistance
- (2014) C. Yoon et al. CLINICAL CANCER RESEARCH
- Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors
- (2014) P. Infante et al. EMBO JOURNAL
- SPOP suppresses tumorigenesis by regulating Hedgehog/Gli2 signaling pathway in gastric cancer
- (2014) Chunyan Zeng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma
- (2014) Sabrina Pricl et al. Molecular Oncology
- Repurposing the FDA-Approved Pinworm Drug Pyrvinium as a Novel Chemotherapeutic Agent for Intestinal Polyposis
- (2014) Bin Li et al. PLoS One
- Inactivation of PTCH1 is associated with the development of cervical carcinoma: clinical and prognostic implication
- (2014) Chandraditya Chakraborty et al. TUMOR BIOLOGY
- Role of PTCH1 gene methylation in gastric carcinogenesis
- (2014) YUN ZUO et al. Oncology Letters
- Gli Protein Activity Is Controlled by Multisite Phosphorylation in Vertebrate Hedgehog Signaling
- (2014) Pawel Niewiadomski et al. Cell Reports
- GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute Single-Arm Phase II Collaborative Study
- (2013) A. Italiano et al. ANNALS OF ONCOLOGY
- U.S. Food and Drug Administration Approval: Vismodegib for Recurrent, Locally Advanced, or Metastatic Basal Cell Carcinoma
- (2013) M. Axelson et al. CLINICAL CANCER RESEARCH
- GLI1 regulates a novel neuropilin-2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiation
- (2013) Hira Lal Goel et al. EMBO Molecular Medicine
- Inhibition mechanism exploration of investigational drug TAK-441 as inhibitor against Vismodegib-resistant Smoothened mutant
- (2013) Tsuyoshi Ishii et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- PTCH1 mutation and local aggressiveness of odontogenic keratocystic tumors in children: is there a relationship?
- (2013) Natacha Kadlub et al. HUMAN PATHOLOGY
- Nonclassical Activation of Hedgehog Signaling Enhances Multidrug Resistance and Makes Cancer Cells Refractory to Smoothened-targeting Hedgehog Inhibition
- (2013) Shamik Das et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Loss of the Transcription Factor GLI1 Identifies a Signaling Network in the Tumor Microenvironment Mediating KRAS Oncogene-induced Transformation
- (2013) Lisa D. Mills et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hedgehog Related Protein Expression in Breast Cancer: Gli-2 Is Associated with Poor Overall Survival
- (2013) Soyoung Im et al. Korean Journal of Pathology
- Altered expression of PTCH and HHIP in gastric cancer through their gene promoter methylation: Novel targets for gastric cancer
- (2013) YU SONG et al. Molecular Medicine Reports
- GLI activation by atypical protein kinase C ι/λ regulates the growth of basal cell carcinomas
- (2013) Scott X. Atwood et al. NATURE
- Evasion of p53 and G2/M checkpoints are characteristic of Hh-driven basal cell carcinoma
- (2013) Z J Li et al. ONCOGENE
- Targeting Gli transcription activation by small molecule suppresses tumor growth
- (2013) G Bosco-Clément et al. ONCOGENE
- Role of the Hedgehog pathway in hepatocellular carcinoma (Review)
- (2013) XIN ZHENG et al. ONCOLOGY REPORTS
- Expression of the Glioma-Associated Oncogene Homolog 1 (Gli1) in Advanced Serous Ovarian Cancer Is Associated with Unfavorable Overall Survival
- (2013) Alessandra Ciucci et al. PLoS One
- Gli as a Novel Therapeutic Target in Malignant Pleural Mesothelioma
- (2013) Hui Li et al. PLoS One
- Gastric cancer (GC) patients with hedgehog pathway activation: PTCH1 and GLI2 as independent prognostic factors
- (2013) Su Jin Lee et al. Targeted Oncology
- The Crosstalk of mTOR/S6K1 and Hedgehog Pathways
- (2012) Yan Wang et al. CANCER CELL
- Hedgehog Gli3 activator signal augments tumorigenicity of colorectal cancer via upregulation of adherence-related genes
- (2012) Hironori Iwasaki et al. CANCER SCIENCE
- Role of Hedgehog Signaling in Malignant Pleural Mesothelioma
- (2012) Y. Shi et al. CLINICAL CANCER RESEARCH
- Expression of Glioma-associated Oncogene Homolog 1 is Associated with Invasion and Postoperative Liver Metastasis in Colon Cancer
- (2012) Yin-lu Ding et al. International Journal of Medical Sciences
- Gli inhibitor GANT61 causes apoptosis in myeloid leukemia cells and acts in synergy with rapamycin
- (2012) Deng Pan et al. LEUKEMIA RESEARCH
- Adult interfollicular tumour-initiating cells are reprogrammed into an embryonic hair follicle progenitor-like fate during basal cell carcinoma initiation
- (2012) Khalil Kass Youssef et al. NATURE CELL BIOLOGY
- Inhibiting the Hedgehog Pathway in Patients with the Basal-Cell Nevus Syndrome
- (2012) Jean Y. Tang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
- (2012) Aleksandar Sekulic et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Transcription Factor GLI1 Mediates TGFβ1 Driven EMT in Hepatocellular Carcinoma via a SNAI1-Dependent Mechanism
- (2012) Xin Zheng et al. PLoS One
- The activity of Gli transcription factors is essential for Kras-induced pancreatic tumorigenesis
- (2012) M. Rajurkar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hedgehog pathway signaling in cervical carcinoma and outcome after chemoradiation
- (2011) Naz Chaudary et al. CANCER
- β-catenin and Gli1 are prognostic markers in glioblastoma
- (2011) Marco Rossi et al. CANCER BIOLOGY & THERAPY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Polymeric Nanoparticle-Encapsulated Hedgehog Pathway Inhibitor HPI-1 (NanoHHI) Inhibits Systemic Metastases in an Orthotopic Model of Human Hepatocellular Carcinoma
- (2011) Yang Xu et al. CLINICAL CANCER RESEARCH
- Kif7 promotes hedgehog signaling in growth plate chondrocytes by restricting the inhibitory function of Sufu
- (2011) S.-H. C. Hsu et al. DEVELOPMENT
- Abrogation of Gli3 expression suppresses the growth of colon cancer cells via activation of p53
- (2011) Han Na Kang et al. EXPERIMENTAL CELL RESEARCH
- GLI2 Is a Potential Therapeutic Target in Pediatric Medulloblastoma
- (2011) Pawel Buczkowicz et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Prognostic value of hedgehog signaling pathway in patients with colon cancer
- (2011) Meihua Xu et al. MEDICAL ONCOLOGY
- Expression and regulation mechanisms of Sonic Hedgehog in breast cancer
- (2010) Wei Cui et al. CANCER SCIENCE
- The Human Glioma-Associated Oncogene Homolog 1 (GLI1) Family of Transcription Factors in Gene Regulation and Diseases
- (2010) Hu Zhu et al. CURRENT GENOMICS
- Suppressor of fused and Spop regulate the stability, processing and function of Gli2 and Gli3 full-length activators but not their repressors
- (2010) C. Wang et al. DEVELOPMENT
- Loss of WNT-TCF addiction and enhancement of HH-GLI1 signalling define the metastatic transition of human colon carcinomas
- (2010) Frédéric Varnat et al. EMBO Molecular Medicine
- β1 integrins mediate cell proliferation in three-dimensional cultures by regulating expression of the sonic hedgehog effector protein, GLI1
- (2010) Hira Lal Goel et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Review: Targeting the Hedgehog pathway in cancer
- (2010) Sachin Gupta et al. Therapeutic Advances in Medical Oncology
- Genetics of basal cell carcinoma
- (2009) Sally E De Zwaan et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- Expression of the glioma-associated oncogene homolog (GLI) 1in human breast cancer is associated with unfavourable overall survival
- (2009) Anette ten Haaf et al. BMC CANCER
- Wnt Signaling Stimulates Transcriptional Outcome of the Hedgehog Pathway by Stabilizing GLI1 mRNA
- (2009) F. K. Noubissi et al. CANCER RESEARCH
- Contrasting activity of Hedgehog and Wnt pathways according to gastric cancer cell differentiation: Relevance of crosstalk mechanisms
- (2009) Jie-Hyun Kim et al. CANCER SCIENCE
- GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation
- (2009) O. Nolan-Stevaux et al. GENES & DEVELOPMENT
- Cloning of the HumanGLI2Promoter
- (2009) Sylviane Dennler et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phase III Trial of Irinotecan/Cisplatin Compared With Etoposide/Cisplatin in Extensive-Stage Small-Cell Lung Cancer: Clinical and Pharmacogenomic Results From SWOG S0124
- (2009) Primo N. Lara et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of p70S6K2 down-regulates Hedgehog/GLI pathway in non-small cell lung cancer cell lines
- (2009) Shinji Mizuarai et al. Molecular Cancer
- Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade
- (2009) J. M. Hyman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis
- (2009) H. Tian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hedgehog signal transduction by Smoothened: Pharmacologic evidence for a 2-step activation process
- (2009) R. Rohatgi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
- (2009) R. L. Yauch et al. SCIENCE
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- Methylation of PTCH1a gene in a subset of gastric cancers
- (2009) Peng Du et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation
- (2008) Xiaoyun Liao et al. CARCINOGENESIS
- Phosphorylation of Gli2 by protein kinase A is required for Gli2 processing and degradation and the Sonic Hedgehog-regulated mouse development
- (2008) Yong Pan et al. DEVELOPMENTAL BIOLOGY
- Characterization of sonic hedgehog as a novel NF-κB target gene that promotes NF-κB-mediated apoptosis resistance and tumor growth in vivo
- (2008) Hubert Kasperczyk et al. FASEB JOURNAL
- Gli2 upregulates cFlip and renders basal cell carcinoma cells resistant to death ligand-mediated apoptosis
- (2008) E Kump et al. ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started